Grantham, Mayo, Van Otterloo & Co (GMO)’s Halliburton HAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.87M Buy
253,231
+216,575
+591% +$7.49M 0.03% 243
2025
Q4
$1.04M Buy
+36,656
New +$968K ﹤0.01% 515
2020
Q4
Sell
-161,153
Closed -$1.94M 835
2020
Q3
$1.94M Sell
161,153
-9,367
-5% -$136K 0.01% 416
2020
Q2
$2.21M Buy
+170,520
New +$1.84M 0.02% 393
2017
Q2
Sell
-700
Closed -$32.1K 603
2017
Q1
$34K Buy
+700
New +$37.6K ﹤0.01% 569
2015
Q3
Sell
-5,600
Closed -$241K 576
2015
Q2
$241K Sell
5,600
-300
-5% -$13.8K ﹤0.01% 425
2015
Q1
$259K Buy
+5,900
New +$246K ﹤0.01% 410
2014
Q2
Sell
-36,878
Closed -$2.17M 523
2014
Q1
$2.17M Sell
36,878
-65,423
-64% -$3.49M 0.01% 406
2013
Q4
$5.19M Sell
102,301
-1,399
-1% -$72.3K 0.01% 308
2013
Q3
$4.99M Sell
103,700
-6,600
-6% -$309K 0.01% 307
2013
Q2
$4.6M Buy
+110,300
New +$4.61M 0.01% 319

Other funds holding HAL

Grantham, Mayo, Van Otterloo & Co (GMO)'s HAL Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Halliburton (HAL) stake by 591% in Q1 2026, buying an estimated $7.49M and bringing the position to 253,231 shares worth $9.87M. The position accounts for 0.03% of the portfolio, ranked #243.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HAL in Q2 2013 and has held it in 11 quarters since. 1,188 funds tracked by Wall St. Rank hold HAL as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 253,231 shares of Halliburton worth $9.87M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 216,575 Halliburton shares in Q1 2026, an estimated $7.49M.
  • Halliburton made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #243 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Halliburton in Q2 2013 and has held it in 11 quarters since.
  • 1,188 funds tracked by Wall St. Rank held Halliburton as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.